Collaboration Agreement By and Between Amgen Inc. and Daiichi Sankyo Company, Limited Dated July 11, 2007Collaboration Agreement • November 9th, 2007 • Amgen Inc • Biological products, (no disgnostic substances) • California
This Collaboration Agreement (this “Agreement”) is entered into as of the 11th day of July, 2007 (the “Effective Date”) by and between Amgen Inc., a Delaware corporation having its principal place of business at One Amgen Center Drive, Thousand Oaks, CA 91320-1799 (“Amgen”) and Daiichi Sankyo Company, Limited, a Japanese corporation with a principal place of business at 3-5-1 Nihonbashi-honcho, Chuo-ku, Tokyo 103-8426 (“Collaborator”). Amgen and Collaborator are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
